ExploreInterventionTriple antithrombotic therapy
Intervention

Triple antithrombotic therapy

Also known as: Triple antithrombotic therapy (DAPT plus oral anticoagulant) after myocardial infarction in patients with concurrent aortic stenosis
3 findings 1 paper 3 related entities View in graph →

Related entities

conditions
outcomes
studys

Findings (27)

None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90

Papers (1)